Products

What will AGI do for Abarelix?

This classification denotes a gonadotropin releasing hormone inhibitor with the molecular formula C72H95ClN14O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W486SJ5824, chemically known as d-alaninamide, n-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n-methyl-l-tyrosyl-d-asparaginyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl- 10 but generally known as abarelix, which bears US NIH Compound Identifier 16131215. European Medicines Agency schedules Abarelix in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07359MIG. The term ABARELIX is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules abarelix in its Anatomical Therapeutic Chemical (ATC) Classification. ABARELIX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule abarelix under HS 29371900 and SITC 54154. As of Q4 2014, ABARELIX remains the US FDA Preferred Term for this commodity. Abarelix bears US NLM identifiers UMLS ID C1174732 and NCI Concept Code C2015. SMILES: CLC1CCC(CC(NC(=O)C(NC(=O)C)CC2CC3C(CC2)CCCC3)C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C(CCC2)C(=O)NC(C)C(=O)N)CCCCNC(C)C)CC(C)C)CC(=O)N)CC2CCC(O)CC2)C)CO)CC2CCCNC2)CC1.